Is Cardinal Health (CAH) a risky stock?
As of July 21, 2026, Clavix grades Cardinal Health (CAH) C- for risk, a composite score of 55 out of 100 on an A+ to F scale, which puts CAH in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind CAH's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how CAH scores on each, as of July 21, 2026.
What's moving CAH's risk right now
Company-specific signals Clavix flags behind CAH's current grade, drawn from recent news and filings as of July 21, 2026.
Kestra Advisory Services LLC trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 12.8% in the 1st quarter, according to its most recent disclosure…
The combination of rising occupancy and falling admissions suggests improved revenue per patient but declining patient volumes overall, which could pressure top-line revenue growt…
Cooper Companies' premium contact lenses, restructuring gains and product launches support growth despite regional and competitive headwinds.
What a C- grade means
On the Clavix A+ to F scale, CAH's composite of 55 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell CAH or any security. Grades are risk indicators, not predictions of return. Data may be delayed.